ArticleNanoscale advances2024
Embedding plasmonic nanoparticles in soft crystals: an approach exploiting CTAB-I structures.
Article in Nanoscale advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Embedding nanoparticles with different functionalities into soft substrates is a convenient tool to realize technologically significant multifunctional materials. This study focuses on incorporating bimetallic plasmonic nanoparticles into soft crystals made of cetyltrimethylammonium bromide-iodide. We observed the emergence of a novel symmetry-lowered cetrimonium crystal polymorph that enables the realization of strong interparticle plasmonic coupling in these composite materials. The observed crystal polymorph exhibits a triclinic structure with significantly reduced unit cell volume compared to standard CTAB. Solid-state nuclear magnetic resonance studies revealed an enhanced cetrimonium chain rigidity and a commensurate decrease in the mobility of the methyl groups. This is attributed to iodide incorporation. To study the influence of these interactions on solution phase dynamical properties, we employed light scattering measurements using gold nanospheres as markers, where we observed aggregation of these particles. We then develop a two step synthetic scheme that successfully enables high levels (533 particles per μm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.